Skip to main content
    V

    Veracyte Inc (VCYT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $44.39
    +0.88 (+2.02%)

    Market Cap: $3.50B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    74%(29/39)
    Avg Surprise
    +78.06%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.41
    Range$0.35 - $0.45
    12 analysts
    EPS RevisionsNo revisions (7d)
    0
    9
    30d
    EPS Estimate DriftChange to current
    90d ago$0.43-4.9%
    60d ago$0.44-5.8%
    30d ago$0.41-0.3%
    7d ago$0.410.0%
    Current$0.41
    Revenue Consensus
    $147M
    Range$145M - $149M
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.74
    Range$0.60 - $0.81
    12 analysts
    Revenue Consensus
    $172M
    Range$168M - $176M
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.74---
    Sep 26EST
    		-$0.41---
    Jun 26
    Reported Jul 30
    		$0.37$0.29+27.59%Beat-15.9%
    Mar 26
    Reported May 5
    		$0.52$0.33+57.58%Beat+67.7%
    Dec 25
    Reported Feb 25
    		$0.53$0.39+35.90%Beat+47.2%
    Sep 25
    Reported Nov 4
    		$0.51$0.32+59.38%Beat+54.5%
    Jun 25
    Reported Aug 6
    		$0.44$0.30+46.67%Beat+46.7%
    Mar 25
    Reported May 7
    		$0.31$0.20+55.00%Beat+675.0%
    Dec 24
    Reported Feb 24
    		$0.36$0.26+40.02%Beat+192.3%
    Sep 24
    Reported Nov 6
    		$0.33$0.17+94.12%Beat+180.5%
    Jun 24
    Reported Aug 6
    		$0.30$-0.01+3100.00%Beat+350.0%
    Mar 24
    Reported May 7
    		$0.04N/A+140.00%Beat+136.4%
    Dec 23
    Reported Feb 22
    		$-0.39$-0.09-333.33%Miss-680.0%
    Sep 23
    Reported Nov 7
    		$-0.41$-0.13-215.38%Miss-241.7%
    Jun 23
    Reported Aug 8
    		$-0.12$-0.14+14.29%Beat+7.7%
    Mar 23
    Reported May 4
    		$-0.11$-0.11+0.00%Beat+45.0%
    Dec 22
    Reported Feb 22
    		$-0.05N/A+66.67%Beat+66.7%
    Sep 22
    Reported Nov 2
    		$-0.12$-0.23+47.83%Beat+40.0%
    Jun 22
    Reported Aug 2
    		$-0.13$-0.22+40.91%Beat+0.0%
    Mar 22
    Reported May 3
    		$-0.20$-0.23+13.04%Beat+69.7%
    Dec 21
    Reported Feb 28
    		$-0.15$-0.16+6.25%Beat-7.1%
    Sep 21
    Reported Nov 9
    		$-0.20$-0.14-42.86%Miss-150.0%
    Jun 21
    Reported Jul 29
    		$-0.13$-0.25+48.00%Beat+40.9%
    Mar 21
    Reported May 10
    		$-0.66$-0.12-450.00%Miss-175.0%
    Dec 20
    Reported Feb 17
    		$-0.14$-0.10-40.00%Miss+6.7%
    Sep 20
    Reported Nov 2
    		$-0.08N/A+57.89%Beat-300.0%
    Jun 20
    Reported Jul 30
    		$-0.22$-0.27+18.52%Beat-340.0%
    Mar 20
    Reported May 6
    		$-0.24$-0.20-20.00%Miss-380.0%
    Dec 19
    Reported Feb 25
    		$-0.15$-0.07-114.29%Miss-87.5%
    Sep 19
    Reported Oct 22
    		$-0.02N/A+71.43%Beat+83.3%
    Jun 19
    Reported Jul 30
    		$-0.05$-0.09+44.44%Beat+72.2%
    Mar 19
    Reported Apr 30
    		$-0.05$-0.07+28.57%Beat+81.5%
    Dec 18
    Reported Feb 25
    		$-0.08$-0.15+46.67%Beat+66.7%
    Sep 18
    Reported Oct 29
    		$-0.12$-0.21+42.86%Beat+42.9%
    Jun 18
    Reported Jul 23
    		$-0.18$-0.26+30.77%Beat+18.2%
    Mar 18
    Reported May 1
    		$-0.27$-0.25-8.00%Miss-12.5%
    Dec 17
    Reported Feb 27
    		$-0.24$-0.20-20.00%Miss-71.4%
    Sep 17
    Reported Nov 6
    		$-0.21$-0.21+0.00%Beat-
    Jun 17
    Reported Jul 31
    		$-0.22$-0.25+12.00%Beat-
    Mar 17
    Reported May 3
    		$-0.24$-0.23-4.35%Miss-
    Dec 16
    Reported Mar 1
    		$-0.14$-0.26+46.15%Beat-

    Key Metrics

    Valuation
    P/E Ratio23.00EV/EBITDA24.11x
    Price/FCF21.39xFCF Yield4.68%
    Profitability
    Profit Margin20.40%Operating Margin15.30%
    ROE8.77%ROIC8.24%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.16xQuick Ratio8.80x
    Trading Statistics
    Beta1.95Avg Volume1.47M
    52-Week High$60.9152-Week Low$29.45

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$44.52
    SMA 20$44.46
    SMA 50$43.59
    SMA 200$42.58
    EMA 10$44.21
    EMA 20$44.18
    EMA 50$44.89
    EMA 200$43.17

    MACD

    Line: -0.00Signal: 0.08Hist: -0.08

    ADX

    ADX: 17.6+DI: 24.9-DI: 17.8

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down16.0
    PSAR$47.45

    Bollinger Bands

    Upper Band$48.39
    Lower Band$40.52
    %B Position1770%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    50.4

    Momentum Oscillators

    Stoch %K31.8
    Stoch %D33.0
    Williams %R-58.4
    ROC (10d)0.5%
    Momentum0.20
    CCI (20d)-8.3
    MFI (14d)35.6

    Volatility Measures

    ATR (14d)$2.43(5.5%)
    StdDev (20d)1.97
    Hist Vol65.9%(High)

    Volume Flow

    VWAP$44.22
    OBV-16.7M
    AD Line8.0M
    CMF (20d)0.034

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio0.8x
    VWMA (20d)$44.49

    Pivot Points

    R3$46.06
    R2$45.02
    R1$44.27
    Pivot Point$43.23
    S1$42.48
    S2$41.44
    S3$40.69

    Advanced Oscillators

    TSI0.12
    Ultimate Osc52.7
    KST53.94

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$150.32M$139.07M$140.64M$131.87M$130.16M$114.47M$118.63M$115.86M$114.43M$96.84M$98.20M$90.11M
    Cost of Revenue$41.77M$37.91M$38.66M$40.59M$40.40M$34.97M$39.88M$36.85M$36.52M$34.38M$38.22M$32.42M
    Gross Profit$108.55M$101.16M$101.97M$91.28M$89.77M$79.51M$78.75M$79.01M$77.91M$62.47M$59.98M$57.69M
    Operating Expenses$88.31M$81.22M$67.48M$71.04M$97.70M$79.19M$77.39M$69.91M$76.22M$70.04M$104.33M$94.24M
    R&D$29.44M$27.10M$20.85M$15.98M$16.26M$17.72M$19.29M$17.57M$16.46M$15.96M$18.67M$13.32M
    SG&A$27.44M$23.68M$17.37M$27.28M$32.33M$33.81M$26.91M$25.74M$31.75M$26.21M$23.80M$16.33M
    Operating Income$22.98M$22.65M$37.20M$22.95M$-5,268,000$2.90M$4.17M$12.02M$4.61M$-4,656,000$-35,507,000$-31,739,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$4.06M$0$0$732,000$0$0$0$0$0
    Income Before Tax$26.52M$29.97M$40.63M$18.89M$1.25M$7.43M$3.44M$16.85M$7.36M$-1,908,000$-30,472,000$-29,772,000
    Income Tax Expense$1.03M$1.27M$-515,000$-248,000$2.23M$381,000$-1,670,000$1.69M$1.63M$-44,000$-2,179,000$-154,000
    Net Income$25.49M$28.71M$41.15M$19.14M$-980,000$7.05M$5.11M$15.15M$5.73M$-1,864,000$-28,293,000$-29,618,000
    EBITDA$30.64M$34.79M$45.28M$24.16M$5.69M$11.91M$9.34M$22.73M$13.10M$3.68M$-24,136,000$-22,449,000
    EBIT$26.52M$29.97M$40.63M$18.89M$1.25M$7.43M$3.44M$16.85M$7.36M$-1,908,000$-30,472,000$-29,772,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VCYT

    Government Contracts

    Gov Obligations (TTM)
    $3.52M
    Gov Obligations / Revenue
    0.6%
    Obligations YoY
    199.5%
    Active Awards
    46
    New Awards (TTM)
    24
    Avg Remaining Term
    9.3 mo

    Top agency: Department of Veterans Affairs at 89.7% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25726N0108Department of Veterans AffairsDepartment of Veterans Affairs$716112Jan 1, 2026
    36C24826F0044Department of Veterans AffairsDepartment of Veterans Affairs$324059Dec 1, 2025
    36C24126N0219Department of Veterans AffairsDepartment of Veterans Affairs$281000Feb 1, 2026
    75H71225F80098Department of Health and Human ServicesIndian Health Service$262760Sep 10, 2025
    36C24826N0322Department of Veterans AffairsDepartment of Veterans Affairs$194435Feb 1, 2026
    36C26326N0391Department of Veterans AffairsDepartment of Veterans Affairs$168000May 1, 2026
    36C25626N0188Department of Veterans AffairsDepartment of Veterans Affairs$165200Apr 1, 2026
    36C25026N0178Department of Veterans AffairsDepartment of Veterans Affairs$129624Nov 15, 2025
    36C26126F0025Department of Veterans AffairsDepartment of Veterans Affairs$129624Oct 1, 2025
    36C26326N0393Department of Veterans AffairsDepartment of Veterans Affairs$112200May 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    VCYT Valuation and Fair Value

    P/E
    23.0x
    Forward P/E
    23.6x
    EV/EBITDA
    24.1x
    P/FCF
    21.4x
    PEG
    0.0x
    P/B
    2.6x
    See GNG's fair value

    VCYT Profitability: Margins, ROIC and FCF

    Gross margin
    71.7%
    Operating margin
    15.3%
    Net margin
    20.4%
    ROIC
    8.2%
    ROE
    8.8%
    FCF margin
    29.5%
    FCF yield
    4.7%

    VCYT Competitors

    CompanyTicker
    iRhythm Technologies IncIRTC
    Legend Biotech CorpLEGN
    Organon & CoOGN
    Pulse Biosciences IncPLSE
    National HealthCare CorporationNHC
    Cidara Therapeutics IncCDTX
    Telix Pharmaceuticals LimitedTLX
    Viking Therapeutics IncVKTX

    Sector: Healthcare

    VCYT Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    9
    Hold
    1
    Sell
    1
    Strong Sell
    0

    VCYT Bull Case vs Bear Case

    Bull case

    • VCYT converts 29.5% of revenue into free cash flow.
    • VCYT has a 20.4% net profit margin.
    • VCYT beat EPS estimates in 100.0% of its last 8 reported quarters.

    VCYT Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    52.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.41
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 9 down

    Frequently Asked Questions About VCYT

    Does VCYT pay dividends?

    Veracyte Inc (VCYT) does not currently pay a regular dividend.

    What is VCYT's P/E ratio?

    Veracyte Inc has a price-to-earnings (P/E) ratio of 23.00.

    What is VCYT's market cap?

    Veracyte Inc (VCYT) has a market capitalization of $3.50B with a current stock price of $44.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In